Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 4:05 AM
Ignite Modification Date:
2025-12-25 @ 4:05 AM
NCT ID:
NCT05707702
Eligibility Criteria:
Inclusion Criteria:
* Presence of biopsy-proven low-grade or mild oral dysplasia
Exclusion Criteria:
* Active oral cavity malignancy
* Active oral cavity high grade dysplasia
* Currently undergoing chemotherapy or immunotherapy, or have used these agents within the prior 6 months
* History of external beam radiation therapy to the head and neck area
* Diagnosis of HIV with decreased CD4 count and/or detectable viral load
* Current use of systemic or orally absorbed steroids
* Patient undergoing stem cell transplantation
* Patients taking anti-rejection medication after stem cell or solid organ transplantation
* Patients using injectable immunosuppressive drugs for autoimmune disease
* Pregnant or nursing women
* Patients who are hospitalized
* Patients with a heart valve abnormalities or a history of valve replacement or endocarditis
* Patients with active severe acute intestinal disease (active bowel leak, acute abdomen, active colitis) or a history of short bowel syndrome
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT05707702
Study Brief:
Protocol Section:
NCT05707702